Showing results (1731-1740 of 2,324) with videos related to
Sort By:
Pageof 233
Expert Opinion on Therapeutic Targets|July 16, 2010
Sulf-2: an extracellular modulator of cell signaling and a cancer target candidateSteven D Rosen, Hassan Lemjabbar-AlaouiExpert Opinion on Therapeutic Targets|November 14, 2015
Novel therapeutic strategies for Clostridium difficile infectionsCan M Ünal, Michael SteinertExpert Opinion on Therapeutic Targets|July 21, 2023
The aquaporin-4 water channel and updates on its potential as a drug target for Alzheimer's diseaseBret Silverglate, Xiaoyi Gao, Hannah P Lee, et al.Expert Opinion on Therapeutic Targets|July 26, 2023
Targets for obstructive sleep apnea pharmacotherapy: principles, approaches, and emerging strategiesRichard L HornerExpert Opinion on Therapeutic Targets|June 14, 2023
Modulating multidrug resistance to drug-based antitumor therapies through NF-κB signaling pathway: mechanisms and perspectivesDapeng Wu, Sai Tian, Wenjing ZhuExpert Opinion on Therapeutic Targets|July 22, 2026
APE1/Ref-1: multifunctional biology, selective inhibition, and the path to clinical translationJessica A Occhiuto, Silpa Gampala, Melissa L Fishel, et al.Expert Opinion on Therapeutic Targets|June 25, 2026
The role of bile acid receptors in cholestatic liver disease: pathophysiological insights and therapeutic advancesHongying Zhou, Jie Yang, Wenbin Wu, et al.Expert Opinion on Therapeutic Targets|May 8, 2026
Targeting the OPA1 pathway in autosomal dominant optic atrophy (ADOA): 25 years from gene discovery to therapeutic strategyMarcel V AlaviExpert Opinion on Therapeutic Targets|May 9, 2026
Targeting the NLRP3 inflammasome with antibody-based Therapeutics for chronic neurodegenerative diseasesJagdeep K Sandhu, Jamshid Tanha, Mehdi Arbabi-GhahroudiExpert Opinion on Therapeutic Targets|August 15, 2026
Interleukin-6 as a therapeutic target in Diabetic macular edema: current evidence and future perspectivesHidetaka Noma, Tatsuya MimuraPageof 233